Sign up now to have the right to view
10 tenders for free.
| Title |
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2A) for Novel Therapeutic Agents for the Spectrum of Alzheimer's Disease (Ad) and Ad-Related Dementias (Adrd) (Ug3 Uh3 Clinical Trial Require... Tender Notice International Competitive Bidding
|
|---|---|
| Country | |
| Language | English |
| Organization | |
| Published Date | 23.08.2023 |
| Deadline Date | 19.11.2026 |
| Overview | Seamless Early-Stage Clinical Drug Development (Phase 1 to 2A) for Novel Therapeutic Agents for the Spectrum of Alzheimer's Disease (Ad) and Ad-Related Dementias (Adrd) (Ug3 Uh3 Clinical Trial Require... Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3 UH3 Clinical Trial Required) Tender are invited for Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3 UH3 Clinical Trial Required) NATIONAL INSTITUTES OF HEALTH NIH OER WebmasterOERWebmaster03@od.nih.gov grantsinfo@nih.gov Tender Notice International Competitive Bidding PAR-23-274 United States of America GT-87730876 |
| NAICS | |
| CPVS |
-
|
| UNSPSC |
|
| Regions | |
| Sectors | URL |
| Share |
United States of America
| Title |
|---|
|
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2A) for Novel Therapeutic Agents for the Spectrum of Alzheimer's Disease (Ad) and Ad-Related Dementias (Adrd) (Ug3 Uh3 Clinical Trial Require... Tender Notice International Competitive Bidding
|
| Country |
| Language |
| English |
| Organization |
| Published Date |
| 23.08.2023 |
| Deadline Date |
| 19.11.2026 |
| Overview |
| Seamless Early-Stage Clinical Drug Development (Phase 1 to 2A) for Novel Therapeutic Agents for the Spectrum of Alzheimer's Disease (Ad) and Ad-Related Dementias (Adrd) (Ug3 Uh3 Clinical Trial Require... Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3 UH3 Clinical Trial Required) Tender are invited for Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3 UH3 Clinical Trial Required) NATIONAL INSTITUTES OF HEALTH NIH OER WebmasterOERWebmaster03@od.nih.gov grantsinfo@nih.gov Tender Notice International Competitive Bidding PAR-23-274 United States of America GT-87730876 |
| NAICS |
| Other Direct Insurance (except Life Direct Insurance (except Life Direct Life International |
| CPVS |
| - |
| UNSPSC |
| - |
| Regions |
| APEC Countries North America Northern America |
| Sectors |
| Printing and Publishing Railways-Rail-Railroad Defence and Security Construction Energy-Power and Electrical Computer Hardwares and Consumables Marine |
| URL |
| Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Tenders